Ph 2B/3 Tafenoquine (TFQ) study in prevention of vivax relapse

Trial Identifier: 112582
Sponsor: GlaxoSmithKline
Collaborator:
Medicines for Malaria Venture
Start Date: April 2014
Primary Completion Date: November 2016
Condition: Parasite Infections

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
Brazil, Amazonas Manaus, Amazonas, Brazil, 69040-000
Brazil, Rondônia Porto Velho, Rondônia, Brazil, 76812-329
Cambodia Oddar Meancheay Province, Cambodia
Ethiopia Gondar, Ethiopia
Ethiopia Jimma, Ethiopia
India Bikaner, India
India Chennai, India, 600016
India Lucknow, India, 226003
India Secunderabad, India, 500 003
Peru, Loreto Iquitos, Loreto, Peru, Iqui 01
Philippines Rio Tuba, Bataraza, Philippines, 5306
Thailand Bangkok, Thailand, 10400
Thailand Tak, Thailand, 63110